Risk stratification and survival in post myocardial infarction patients: A large prospective and multicenter study in Japan

International Journal of Cardiology

Volumn 93, Issue 2-3, 2004, Pages 263-268

  Ohno, Jun ^a   Watanabe, Eiichi ^b   Toyama, Junji ^c   Kawamura, Takashi ^d   Ohno, Miyoshi ^e   Kodama, Itsuo ^f  

^a Nagoya Higashi Health Center   (Japan)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Aichi Prefectural Owari Hospital   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^f NAGOYA UNIVERSITY   (Japan)

Author keywords

Arrhythmia; Prognosis; Reperfusion

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AMBULATORY MONITORING; ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY RISK; ELECTROCARDIOGRAPHY MONITORING; FEMALE; FOLLOW UP; HEART DEATH; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE REPERFUSION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HOSPITAL ADMISSION; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; RANK SUM TEST; RISK ASSESSMENT; SURVIVAL RATE;

EID: 1242339758     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(03)00215-8     Document Type: Article

References (25)

1. Peterson E.D., Shaw L.J., Califf R.M. Risk stratification after myocardial infarction. Ann Intern Med. 126:1997;561-582.
2. Michaels A.D., Goldschlager N. Risk stratification after acute myocardial infarction in the reperfusion era. Prog Cardiovasc Dis. 42:2000;273-309.
3. Fukiyama K., Kimura Y., Wakugami K., Muratani H. Incidence and long-term prognosis of initial stroke and acute myocardial infarction in Okinawa, Japan. Hypertens Res. 23:2000;127-135.
4. Kubota I., Matsui M., Ito H., et al. Long-term prognosis after recovery from myocardial infarction: a community-based survey in Yamagata, Japan. Intern Med. 40:2001;589-593.
5. Chesebro J.H., Knatterud G., Roberts R., et al. Thrombolysis in Myocardial Infarction (TIMI) Trial. Phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge. Circulation. 76:1987;142-154.
6. Maggioni A.P., Zuanetti G., Franzosi M.G., et al. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results. Circulation. 87:1993;312-322.
7. Long-term effects of intravenous anistreplase in acute myocardial infarction: final report of the AIMS study. Lancet. 335:1990;427-431.
8. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. New Engl J Med. 321:1989;406-412.
9. Hosoda S., Kimata S., Tamura K., et al. Follow-up of 2,733 Japanese patients with myocardial infarction. Jpn Circ J. 59:1995;121-129.
10. Ruberman W., Weinblatt E., Goldberg J.D., Frank C.W., Chaudhary B.S., Shapiro S. Ventricular premature complexes and sudden death after myocardial infarction. Circulation. 64:1981;297-305.
11. Risk stratification and survival after myocardial infarction. New Engl J Med 1983;309:331-6.
12. Bigger J.T. Jr., Weld F.M. Analysis of prognostic significance of ventricular arrhythmias after myocardial infarction. Shortcomings of Lown grading system. Br Heart J. 45:1981;717-724.
13. Bigger J.T. Jr., Weld F.M., Rolnitzky L.M. Prevalence, characteristics and significance of ventricular tachycardia (three or more complexes) detected with ambulatory electrocardiographic recording in the late hospital phase of acute myocardial infarction. Am J Cardiol. 48:1981;815-823.
14. Bigger J.T. Jr., Fleiss J.L., Kleiger R., Miller J.P., Rolnitzky L.M. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation. 69:1984;250-258.
15. Kostis J.B., Byington R., Friedman L.M., Goldstein S., Furberg C. Prognostic significance of ventricular ectopic activity in survivors of acute myocardial infarction. J Am Coll Cardiol. 10:1987;231-242.
16. Touboul P., Andre-Fouet X., Leizorovicz A., et al. Risk stratification after myocardial infarction. A reappraisal in the era of thrombolysis. The Groupe d'Etude du Pronostic de l'Infarctus du Myocarde (GREPI). Eur Heart J. 18:1997;99-107.
17. Hohnloser S.H., Klingenheben T., Zabel M., Schopperl M., Mauss O. Prevalence, characteristics and prognostic value during long-term follow-up of nonsustained ventricular tachycardia after myocardial infarction in the thrombolytic era. J Am Coll Cardiol. 33:1999;1895-1902.
18. The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction. New Engl J Med. 329:1993;1615-1622.
19. Volpi A., Cavalli A., Santoro E., Tognoni G. Incidence and prognosis of secondary ventricular fibrillation in acute myocardial infarction. Evidence for a protective effect of thrombolytic therapy. GISSI Investigators. Circulation. 82:1990;1279-1288.
20. Eldar M., Leor J., Hod H., et al. Effect of thrombolysis on the evolution of late potentials within 10 days of infarction. Br Heart J. 63:1990;273-276.
21. Weiss J.N., Chen P.S., Qu Z., Karagueuzian H.S., Garfinkel A. Ventricular fibrillation: how do we stop the waves from breaking? Circ Res. 87:2000;1103-1107.
22. Moss A.J., Hall W.J., Cannom D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. New Engl J Med. 335:1996;1933-1940.
23. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. New Engl J Med. 346:2002;877-883.
24. Doulalas A.D., Flather M.D., Pipilis A., et al. Evolutionary pattern and prognostic importance of heart rate variability during the early phase of acute myocardial infarction. Int J Cardiol. 77:2001;169-179.
25. La Rovere M.T., Pinna G.D., Hohnloser S.H., et al. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials. Circulation. 103:2001;2072-2077.